4processed

Form 4 — Insider Transaction

Immuneering Corp(IMRX)

Filing Date

June 23, 2026

Accepted

June 23, 2026

Accession No.

0001790340-26-000078

CIK

0001790340

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Zeskind Benjamin J.PRESIDENT AND CEOOther2.4K$4.5622.32MClass A Common StockJun 23, 2026